Noxopharm Limited (ASX:NOX)
Australia · Delayed Price · Currency is AUD 0.0730
-0.0040 (-5.19%)
Jun 19, 2026, 2:49 PM AEST
Noxopharm Market Cap
Noxopharm has a market cap or net worth of 22.43 million as of June 18, 2026. Its market cap has decreased by -0.33% in one year.
Market Cap
22.43M
Enterprise Value
26.58M
Revenue
3.40M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.07
Market Cap Chart
Since August 9, 2016, Noxopharm's market cap has increased from 13.91M to 22.43M, an increase of 61.28%. That is a compound annual growth rate of 4.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 19, 2026 | 22.43M | -17.48% |
| Dec 31, 2025 | 27.18M | - |
| Dec 31, 2024 | 27.18M | 30.99% |
| Dec 29, 2023 | 20.75M | -51.03% |
| Dec 30, 2022 | 42.37M | -62.82% |
| Dec 31, 2021 | 113.97M | -9.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 9, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurizon Therapeutics | 46.27M |
| Nexsen | 45.04M |
| Patrys | 30.00M |
| EZZ Life Science Holdings | 24.00M |
| Algorae Pharmaceuticals | 21.24M |
| NeuroScientific Biopharmaceuticals | 20.62M |
| Neurotech International | 19.77M |
| Opthea | 19.15M |